These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25830485)

  • 21. Expanding role of SK channels in cardiac electrophysiology.
    Mahida S
    Heart Rhythm; 2014 Jul; 11(7):1233-8. PubMed ID: 24681007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antiarrhythmic effect of combining inhibition of Ca²⁺-activated K⁺ (SK) channels and voltage-gated Na⁺ channels in an isolated heart model of atrial fibrillation.
    Kirchhoff JE; Diness JG; Sheykhzade M; Grunnet M; Jespersen T
    Heart Rhythm; 2015 Feb; 12(2):409-18. PubMed ID: 25496982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New class III antiarrhythmic drugs for treatment of atrial fibrillation].
    Maĭkov EB
    Kardiologiia; 2012; 52(11):56-65. PubMed ID: 23237397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of SK Channels: Insight Into Therapeutics of Atrial Fibrillation.
    Qi MM; Qian LL; Wang RX
    Heart Lung Circ; 2021 Aug; 30(8):1130-1139. PubMed ID: 33642173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
    Anderson ME
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel agents for the acute conversion of atrial fibrillation: focus on vernakalant.
    Cialdella P; Pedicino D; Santangeli P
    Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):1-8. PubMed ID: 21235460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.
    Barekatain A; Razavi M
    Tex Heart Inst J; 2012; 39(4):532-4. PubMed ID: 22949771
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R; Sauter DRP; Grunnet M; Diness JG; Bentzen BH
    Eur J Pharmacol; 2017 May; 803():118-123. PubMed ID: 28322838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.
    Fu X; Pan Y; Cao Q; Li B; Wang S; Du H; Duan N; Li X
    BMC Cardiovasc Disord; 2018 Apr; 18(1):63. PubMed ID: 29636010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].
    Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.
    Skibsbye L
    Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036893
    [No Abstract]   [Full Text] [Related]  

  • 35. A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
    Wolbrette DL; Hussain S; Maraj I; Naccarelli GV
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):3-10. PubMed ID: 29940780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
    Comtois P; Sakabe M; Vigmond EJ; Munoz M; Texier A; Shiroshita-Takeshita A; Nattel S
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1489-504. PubMed ID: 18676686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
    Skibsbye L; Ravens U
    Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
    Doshi D; Morrow JP
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].
    Hammwöhner M; D'Alessandro A; Dobrev D; Kirchhof P; Goette A
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):73-80. PubMed ID: 16786465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.